Description
An inhibitor of PDE4 (IC50 = 2.8 nM); selective for PDE4 over PDE1, PDE2, PDE3, and PDE5 with only 46.1, 51.6, 69.4, and 57.4% inhibition, respectively, at 30 µM; inhibits cytokine production in isolated human lymphocytes and monocytes (IC50s = 0.49-3.1 nM); reduces ear thickness in a mouse model of oxazolone-induced skin inflammation at 0.003-0.3%; reduces oxazolone-induced scratching in mice at 0.003-0.3%; reduces the severity of skin lesions in a model of mite-induced atopic dermatitis; inhibits LTB4 production in mouse skin, as well as reduces scratching and cutaneous nerve firing induced by SLIGRL-NH2 in mice
Formal name: 4-[[[3-[6,7-dimethoxy-2-(methylamino)-4-quinazolinyl]phenyl]amino]carbonyl]-benzoic acid, methyl ester
Synonyms: RVT-501
Molecular weight: 472.5
CAS: 947620-48-6
Purity: ≥98%
Formulation: A solid